Icon teams with Dublin university for drug development

Icon ($ICLR) has entered into a strategic partnership with University College Dublin, teaming up with its hometown school to develop drugs, fund a fellowship and help construct a new science center for the university. Both institutions say the deal will strengthen the bond between academic research and industry, allowing the two to share resources and expertise. "It is important that we continue to develop our scientific capabilities and build a pool of talent that can support our growth plans," Icon CEO Ciaran Murray said. Report

Suggested Articles

The platform uses wearables to continuously collect clinical data from study participants and applies machine learning to analyze the data.

WuXi AppTec has cut the ribbon on its expanded Laboratory Testing Division in New Jersey as it looks to boost its integrated testing service portfolio.

St. Jude, Microsoft and DNAnexus have created a data-sharing and analysis platform to help accelerate pediatric cancer research.